Posted: 5 November 2021
You’re invited to have your say on the Biotechnology Blueprint, the Australian biotechnology industry’s decadal strategy.
The Biotechnology Blueprint (the Blueprint) is a shared vision for the industry, by the industry. Led by AusBiotech, and developed together with more than 200 stakeholders, the Blueprint charts a course that will allow the Australian biotechnology sector to shift the horizon of possibility, and reach its ambitions for the coming decade.
The strategy responds to well-articulated, stubborn issues that the industry has grappled with for years, and presents a solutions-based approach.
We need to hear from you: what does success look like? What gaps remain, and how could we address these?
As the national voice of the biotechnology industry, AusBiotech is warmly inviting the sector to have their say.
The sector’s decadal framework is an opportunity for our industry to speak with one voice, identifying key policy priorities that can deliver benefits both for the industry and for the nation as a whole.
While AusBiotech led its development, it encompasses the entire ecosystem, including the work of numerous industry and advocacy organisation collaborators, that will be required to deliver on the vision.
AusBiotech seeks feedback on any part of the Blueprint, but has also posed specific consultation questions, regarding:
- The scope of the Blueprint: accuracy and appropriateness
- Capital and growth: VC, superannuation, tactics to lift commercialisation, international models
- Sovereign capability: increasing domestic toxicology capability, manufacturing, talent and skills development.
- Metrics and data: importance, appropriateness, and priority
- Agricultural biotechnology: suitability of approach
- Sustainability: sector-wide sustainability framework (Environmental, Social and Governance framework)
- Proof of concept fund: effectiveness, size, and global examples
Read more about and download the draft decadal strategy, and submit your feedback on the draft Biotechnology Blueprint now. To request a Word version for tracking, please contact AusBiotech. Consultation meetings are available on request.
READ MORE
HAVE YOUR SAY
